Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis - sprookjes - yvandenbroek - TriplyDB

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

http://www.wikidata.org/entity/Q28271386

about

Community acquired bacterial pneumonia Oxygen therapy for pneumonia in adults Azithromycin for acute lower respiratory tract infections The impact of diabetes on the pathogenesis of sepsis BTS Guidelines for the Management of Community Acquired Pneumonia in Adults Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia--a case-control study.Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward A Global Theme Issue: Bibliography of References Smoking and the outcome of infection.Impact of pneumococcal conjugate vaccination: a retrospective study of hospitalization for pneumonia in North-East Italy Clinical efficacy of intravenous followed by oral azithromycin monotherapy in hospitalized patients with community-acquired pneumonia. The Azithromycin Intravenous Clinical Trials Group Cardiac complications in patients with community-acquired pneumonia: a systematic review and meta-analysis of observational studies Tools for outcome prediction in patients with community acquired pneumonia.Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the De Infection hospitalization increases risk of dementia in the elderly In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.Bronchopulmonary disposition of the ketolide telithromycin (HMR 3647).The burden of community-acquired pneumonia in the elderly: the Spanish EVAN-65 study Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients.The Queensland experience of participation in a national drug use evaluation project, Community-Acquired Pneumonia Towards Improving Outcomes Nationally (CAPTION).Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia.Influence of socioeconomic status on community-acquired pneumonia outcomes in elderly patients requiring hospitalization: a multicenter observational study.Community-acquired pneumonia caused by carbapenem-resistant Streptococcus pneumoniae: re-examining its prevention and treatment.Community-acquired Pseudomonas aeruginosa-pneumonia in a previously healthy man occupationally exposed to metalworking fluids Recent advances in the management of pleural sepsis: what is the evidence?Alcohol abuse and pulmonary disease.Pneumococcal peritonitis: Still with us and likely to increase in importance.The next generation: fluoroquinolones in the management of acute lower respiratory infection in adults Effects of a pneumonia clinical pathway on time to antibiotic treatment, length of stay, and mortality.Severity prediction rules in community acquired pneumonia: a validation study Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia.Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection.Pneumococcal pneumonia: differences according to blood culture results.Community-acquired pneumonia in elderly patients.Assessing the burden of diabetes mellitus in emergency departments in the United States: the National Hospital Ambulatory Medical Care Survey (NHAMCS)A review of clinical trials with fluoroquinolones with an emphasis on new agents.The accuracy of present-on-admission reporting in administrative data.

P2860

Q22241379-A1D905EB-4438-4F17-B1E1-956A6FA957C1 Q22252973-FFCB878F-CB28-40BB-92CB-0B9128C06DB4 Q24245859-2E13750D-125F-434D-8669-D12EACF5345B Q24616935-9A490C4D-7BFD-4138-995A-93508B4B2FEA Q24675547-C13F78C5-DAE0-4B24-87AF-60230F2A7375 Q24678793-E40FB8B0-5425-43D5-8775-AF93A34D8738 Q24794053-90525E01-492E-4B9D-9258-AEAC68847950 Q26865184-1EFC27C5-0BF5-464B-BCED-18550F7326E2 Q27487894-F4E0DF65-6E56-4DAF-9677-AE9A504344E4 Q27687123-702AD52C-B5FB-4953-8CD2-9C64EAA60389 Q28075109-2D331623-BD16-44F1-A193-5B3DDEC40BC6 Q28344357-C92F5250-72D2-4F19-BA62-DD76D22D06ED Q28743162-65264DAE-43FD-4256-BA33-C8562325227D Q30240254-58A045F5-8C08-45CE-AC2C-F337E4F735C6 Q30359034-D4859CF3-5DD8-4CF0-A5BB-DB8B05053E1B Q30405460-393AB2E7-35F2-4DEC-9079-A6F9A5D53FA2 Q30612482-DBC500AF-3CF3-43BF-ADB4-CFB054C9286C Q30662421-C4E49094-02E0-42E6-B998-820F25C79145 Q33347005-BFC5228D-1168-402D-9C6E-D75D5BFFBAC5 Q33420342-C9DC1890-C1AF-4E67-AD5C-39A4EEDE90AE Q33489098-F282C6DE-D458-4C77-BE57-9A799A819FB8 Q33501357-9E7A3E50-F5C2-4D98-9833-28DBE4AE0EDA Q33633380-B7DF3DFD-23A2-4DD2-ABC1-55D8A14AF7BF Q33685738-687498B1-5138-4BFA-8EFA-7CEDDA7A6BB3 Q33727224-ADF09D8E-61B8-47DE-9F1A-05314E923453 Q33734062-19585FA1-46BD-4124-ACB4-F99669ADC26F Q33755478-E8EF6580-13F8-4721-BA97-36951BB6C015 Q33780023-78860DBF-F505-4596-A33B-3B81CEC0876C Q33801878-F1C59F65-AA2B-4CCB-86EA-0939DB96ADF1 Q33803362-A67FFA2F-B2A3-4721-A04A-D5D089EE2B91 Q33840805-DDF8DA6F-22DE-447E-99A8-FE23A69A8177 Q33885194-7001CD83-F795-442A-AFE0-4F9E46A76F48 Q33886611-8F893613-F3EC-4327-80E3-D3A83B3CB12B Q33973580-429D9019-A72A-4E92-9164-305535ED4FE1 Q33976517-49007332-E026-4928-91B8-641D130D16A4 Q34021594-E4709406-0055-4ED9-BBFA-56532E7098C5 Q34048462-500C319A-EC3D-4349-A788-45AB9670EF2F Q34051619-87A376EA-0C43-4931-BBDA-D76235BE2F32 Q34074724-35160B44-D11C-4F18-BA93-E80FA781C94F Q34076496-6D5BBB49-7650-48FD-AC5F-5FFD9A8D6FA6

P2860

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

http://www.wikidata.org/entity/Q28271386

description

1996 nî lūn-bûn

@nan

1996 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1996 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

name

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@ast

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@en

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@nl

type

label

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@ast

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@en

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@nl

prefLabel

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@ast

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@en

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@nl

P1433

Q28271386-072F8474-03D0-4816-B4A0-B035FFF6D736

P1476

Q28271386-6302225C-AE97-44EE-881D-040DC5488EB4

P2093

Q28271386-25FFBD75-CE59-426A-9D20-DCDC625E5729

Q28271386-2768F14F-DCFC-47A9-90DF-ECCC123C558F

Q28271386-39D98AC4-EC7B-4AA3-B42C-F9823F375C38

Q28271386-63BD0C25-AC46-4144-B77F-D3FE7656D9A7

Q28271386-889593A9-950A-4D77-A621-6684943514F6

Q28271386-A2CA6C33-20B6-472E-9458-1900BA688849

Q28271386-AD51A3C4-C28A-44AB-A97F-986230805813

P304

Q28271386-65CBD23A-F545-43E3-A3A5-17128EF50F01

P31

Q28271386-753E5F97-A34E-4442-8847-FDA7A10C6932

Q28271386-7871074E-4B26-460B-BB02-085A2A803CA8

P3181

Q28271386-2BDAA457-A534-4479-AB82-24738C5F28D2

Q28271386-411A9D1E-FEEE-401D-98F4-69B14CA731CA

P356

Q28271386-7ED1EB8C-C215-4D0F-A612-82493785CBC4

Q28271386-8BCB322B-9703-49AD-8D05-7225B2A0BEB5

P407

Q28271386-F45B7117-D0D3-4D81-B8A6-635551BB92AD

P433

Q28271386-F7A77BD1-4EE1-4DFA-AF17-4124F7F759F2

P478

Q28271386-E8D41193-50AE-4687-BBCA-84608957FC14

P577

Q28271386-52814127-465A-4916-AF3E-CA816BA52D00

P698

Q28271386-21ED7A58-4838-4268-8E59-A3B8BDC5E74D

P921

Q28271386-2C69A074-695F-4B2E-90BA-746C5C1C50AC

Q28271386-55CE119B-3EC8-4F85-BB7B-1FD7E6224675

Q28271386-F0A21600-6A45-4A8C-AA02-38D8070AF57A

P3181

P356

JAMA.1996.03530260048030

P1433

Journal of the American Medical Association

P1476

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

@en

P2093

C A Carson

http://www.w3.org/2001/XMLSchema#string

L A Weissfeld

http://www.w3.org/2001/XMLSchema#string

M A Smith

http://www.w3.org/2001/XMLSchema#string

M J Fine

http://www.w3.org/2001/XMLSchema#string

S S Mutha

http://www.w3.org/2001/XMLSchema#string

S S Sankey

http://www.w3.org/2001/XMLSchema#string

W N Kapoor

http://www.w3.org/2001/XMLSchema#string

P304

134-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

132648

http://www.w3.org/2001/XMLSchema#string

4702643

http://www.w3.org/2001/XMLSchema#string

P356

10.1001/JAMA.1996.03530260048030

http://www.w3.org/2001/XMLSchema#string

10.1001/JAMA.275.2.134

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

275

http://www.w3.org/2001/XMLSchema#string

P577

1996-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

8531309

http://www.w3.org/2001/XMLSchema#string

P921